Microdosing involves taking smaller-than-usual quantities of a psychoactive substance in the hope of changing mood, concentration or creativity. Low doses of psilocybin and LSD have attracted the most research. Positive personal accounts are common, but controlled studies do not establish reliable additional benefits for most people’s cognition or wellbeing.
What does microdosing mean?
In everyday use, it means smaller doses intended to avoid strong intoxication. There is no single scientifically established dosing scheme. Different substances, strengths and sensitivities make comparisons difficult, so one person’s account is not a general guide.
Why is it discussed?
People often hope for better focus, less stress or greater creativity. These are primarily reported goals rather than proven treatments. Expectations are difficult to separate from drug effects: believing something beneficial has been taken can change how someone feels through placebo effects.
What have placebo-controlled studies found?
A double-blind study published in Translational Psychiatry in 2022 involved 34 people planning to microdose psilocybin mushrooms. Researchers observed some noticeable changes but no convincing improvement in wellbeing, creativity or cognition over placebo. Some measures instead shifted slightly towards poorer performance.

Two later placebo-controlled studies likewise did not find reliable cognitive or emotional improvements beyond placebo. This does not prove nobody feels anything; it shows claimed benefits cannot be generalised from current data.
A 2024 review also noted physiological or subjective changes in some studies and limitations in study size and methods. A categorical claim that microdosing is definitely only placebo is therefore unjustified too.
Risks and unanswered questions
Psychoactive substances can have adverse effects at low quantities, including anxiety, sleep problems, unpleasant physical sensations or interactions. Unregulated products add uncertainty about composition and strength. High-quality evidence on long-term frequent microdosing remains limited.
Microdosing is not an evidence-based substitute for treatment of depression, anxiety or attention disorders. Symptoms disrupting daily life warrant professional healthcare advice.
Are small amounts of cannabis the same thing?
The term is sometimes used for cannabis products. That does not allow psilocybin or LSD findings to be transferred directly to THC: cannabinoids have different mechanisms and risks. See What Is Cannabis?.
A subject for research, not established promises
Microdosing deserves serious investigation, but strong claims about creativity, productivity or mental health exceed the evidence. Success stories are best approached with interest and critical judgment.
